Export financials
CoreCivic (CXW)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.

CoreCivic Income Statement 2025-2007 | CXW
Brief overview of revenue and earnings at CoreCivic
The overview follows changes across a five-year period. The revenue attributed to CoreCivic moved from $1.9 billion to $2.2 billion between the two endpoints. Across the full period, sales moved by +16%; the average annual rate was 3%. Sales changed only slightly and remained broadly flat.
Over the period, EBITDA shifted from 151 million dollars to 129 million dollars, a change of −14.6%. The operating result developed less favorably than sales. Comparing the endpoints gives EBITDA margins of 7.9% and 5.8%. Operating return per unit of revenue declined.
The net result moved from $54.2 million to $117 million, or +115.1%. The final result improved faster than the scale of the business.
The five-year change in capitalization reached +129.2%: from $783 million to $1.8 billion. The market broadly confirmed the positive direction of the business.
Overall conclusion
The figures do not all move in the same direction. Key strengths include net-income growth. Caution is warranted because of a softer top-line trend and a declining EBITDA margin. Investors should continue to monitor margins, costs, and earnings quality.
Annual Income Statement CoreCivic
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.79 B | 2.02 B | 1.63 B | 1.23 B | 1.2 B | 783 M | 1.95 B | 2.32 B | 2.69 B | 3.41 B | 3.37 B | 4.57 B | 3.71 B | 3.75 B | 2.45 B | 2.17 B | 1.88 B | - | - |
Shares |
107 M | 111 M | 114 M | 118 M | 120 M | 120 M | 119 M | 119 M | 118 M | 117 M | 117 M | 116 M | 110 M | 99.5 M | 105 M | 110 M | 116 M | - | - |
Historical Prices |
16.8 | 18.2 | 14.3 | 10.4 | 9.97 | 6.55 | 16.3 | 15.2 | 17.8 | 18.2 | 18 | 22.9 | 18.8 | 16.6 | 9.39 | 19.8 | 16.2 | 26 | 32.1 |
Net Income |
117 M | 68.9 M | 67.6 M | 122 M | -51.9 M | 54.2 M | 189 M | 159 M | 178 M | 220 M | 222 M | 195 M | 301 M | 157 M | 163 M | 157 M | 155 M | 151 M | - |
Revenue |
2.21 B | 1.96 B | 1.9 B | 1.85 B | 1.86 B | 1.91 B | 1.98 B | 1.84 B | 1.77 B | 1.85 B | 1.79 B | 1.65 B | 1.69 B | 1.76 B | 1.74 B | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | 558 M | 521 M | 516 M | 574 M | 537 M | 491 M | 474 M | 508 M | 532 M | - | - | - | - |
Operating Income |
- | - | - | - | - | 163 M | 282 M | 249 M | 260 M | 296 M | 281 M | 240 M | 251 M | 305 M | 332 M | 324 M | 307 M | 293 M | - |
Interest Expense |
62.2 M | 67.4 M | 73 M | 85 M | 85.5 M | 83.3 M | 84.4 M | -156 K | 90 K | -489 K | 58 K | 1.2 M | 45.1 M | 58.4 M | 72.9 M | 71.1 M | 72.8 M | 59.4 M | - |
EBITDA |
129 M | 128 M | 127 M | 128 M | 135 M | 314 M | 431 M | 414 M | 408 M | 467 M | 433 M | 384 M | 370 M | 419 M | 441 M | 431 M | 408 M | 385 M | - |
Operating Expenses |
- | - | - | - | - | -163 M | 272 M | 263 M | 255 M | 274 M | 255 M | 220 M | 216 M | 203 M | 200 M | -324 M | -307 M | - | - |
General and Administrative Expenses |
170 M | 152 M | 136 M | 128 M | 136 M | 124 M | 127 M | 107 M | 108 M | 107 M | 104 M | 106 M | 104 M | 88.9 M | 91.2 M | 84.1 M | 86.5 M | 80.3 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement CoreCivic
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
91.9 M | 98.9 M | 98.7 M | -1.28 M | 107 M | 109 M | 109 M | -235 K | 110 M | 111 M | 112 M | 114 M | 114 M | 114 M | 115 M | -1.08 M | 117 M | 121 M | 121 M | 31 M | 120 M | 120 M | 120 M | 26 K | 120 M | 120 M | 119 M | 119 M | 119 M | 119 M | 119 M | 119 M | 119 M | 119 M | 118 M | 40 M | 118 M | 118 M | 118 M | 24 K | 117 M | 117 M | 117 M | 60 M | 117 M | 117 M | 117 M | -233 M | 116 M | 116 M | 116 M | 116 M | 116 M | 115 M | 101 M | 100 M | 100 M | 100 M | 99.9 M | 99.5 M | 99.6 M | 107 M | 108 M | 110 M | 110 M | 112 M |
Net Income |
1.34 B | 37.1 M | 37.9 M | 26.5 M | 26.3 M | 38.5 M | 25.1 M | 19.3 M | 21.1 M | 19 M | 9.54 M | 26.5 M | 13.9 M | 14.8 M | 12.4 M | 24.4 M | 68.3 M | 10.6 M | 19 M | 28 M | 30 M | 15.6 M | -126 M | -26.8 M | 26.7 M | 22.2 M | 32.1 M | 42 M | 49 M | 48.6 M | 49.3 M | 41.2 M | 41 M | 39.2 M | 37.8 M | 41.3 M | 41.2 M | 45.5 M | 50 M | 60.7 M | 55.3 M | 57.6 M | 46.3 M | 48.6 M | 50.7 M | 65.3 M | 57.3 M | 30 M | 57.5 M | 55.7 M | 51.7 M | 47.5 M | 51.8 M | 20.4 M | 181 M | 45.4 M | 42.3 M | 37.3 M | 31.7 M | 40.5 M | 39.2 M | 42.4 M | 40.3 M | 43.7 M | 42 M | 36.6 M |
Revenue |
744 M | 685 M | 615 M | 604 M | 580 M | 538 M | 489 M | 479 M | 492 M | 490 M | 501 M | 491 M | 484 M | 464 M | 458 M | 471 M | 464 M | 457 M | 453 M | 472 M | 471 M | 465 M | 455 M | 473 M | 468 M | 473 M | 491 M | 498 M | 509 M | 490 M | 484 M | 482 M | 463 M | 450 M | 441 M | 441 M | 443 M | 436 M | 446 M | - | - | 453 M | 438 M | 439 M | 450 M | 450 M | 417 M | 414 M | 399 M | 400 M | 399 M | 428 M | 420 M | 424 M | 416 M | 427 M | 434 M | 441 M | 435 M | 437 M | 432 M | 430 M | 425 M | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.54 M | 19.2 M | 45.2 M | 39.2 M | 59 M | 66.3 M | 71.1 M | 71 M | 73.3 M | 64.6 M | 64.4 M | 61.7 M | 58.7 M | 65.3 M | 60.8 M | 65.3 M | 69 M | 80.4 M | 74 M | 77.2 M | 64.9 M | 66.5 M | 65.4 M | 79.8 M | 68.8 M | 41.8 M | 69.8 M | 65.5 M | 63.1 M | 56 M | 67.3 M | 68 M | 59.9 M | 80.3 M | 79.7 M | 75.1 M | 69.5 M | 82.4 M | 80.9 M | 87.1 M | 83.6 M | 87.1 M | 85.2 M | 78.2 M |
Interest Expense |
810 K | 797 K | -8 K | -223 K | 4 K | -35 K | -35 K | 1.19 M | 767 K | 444 K | 18.6 M | 619 K | -74 K | 78 K | -47 K | 52 K | -71 K | 21.7 M | 1.04 M | -105 K | 49 K | -8 K | -148 K | -188 K | 11 K | 169 K | 533 K | -737 K | 360 K | 258 K | -4 K | -117 K | -49 K | -33 K | 43 K | -18 K | 65 K | 60 K | -17 K | -386 K | -54 K | -132 K | 83 K | -295 K | 363 K | -36 K | 26 K | 61 K | 143 K | 613 K | 387 K | -20 K | 184 K | 37 K | -101 K | -37 K | 422 K | -41 K | -12 K | -43 K | -73 K | -118 K | -71 K | -116 K | 131 K | 16 K |
EBITDA |
33.9 M | 35.8 M | 33.3 M | -94.2 M | 33.4 M | 31.1 M | 30.5 M | - | 32.2 M | 32.1 M | - | -94.7 M | 32.5 M | 31.6 M | 31 M | - | 31.9 M | 32.3 M | 32 M | -98.9 M | 34 M | 34.1 M | 39.3 M | -86.1 M | 83 M | 77.9 M | 97 M | -34.7 M | 108 M | 107 M | 109 M | -45 M | 104 M | 100 M | 96.8 M | -40.9 M | 97.3 M | 102 M | 105 M | -44.1 M | 117 M | 120 M | 107 M | -40.3 M | 107 M | 118 M | 97.5 M | -42.2 M | 98.1 M | 94.3 M | 91.4 M | 85.6 M | 95.4 M | 95.6 M | 87.3 M | 108 M | 108 M | 103 M | 97.8 M | 110 M | 107 M | 114 M | 111 M | 87.1 M | 111 M | 104 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -6.54 M | -19.2 M | -45.2 M | -39.2 M | -59 M | -66.3 M | -71.1 M | -71 M | -73.3 M | -64.6 M | -64.4 M | -61.7 M | -58.7 M | -65.3 M | -60.8 M | -65.3 M | -69 M | -80.4 M | -74 M | 310 M | 309 M | 303 M | 321 M | 312 M | 292 M | 293 M | 275 M | 282 M | 286 M | 312 M | 298 M | 299 M | 294 M | -80.3 M | -79.7 M | -75.1 M | -69.5 M | -82.4 M | -80.9 M | -87.1 M | -83.6 M | - | -85.2 M | -78.2 M |
General and Administrative Expenses |
56.4 M | 44.1 M | 43.7 M | 44.4 M | 45.3 M | 43.9 M | 36 M | 40.5 M | 41.2 M | 33.9 M | 36.5 M | 36.9 M | 33.9 M | 32.6 M | 32.7 M | 34.9 M | 30.2 M | 31.5 M | 31.1 M | 38.4 M | 34.6 M | 33.2 M | 29.5 M | 27 M | 35.9 M | 30.1 M | 31.3 M | 32.2 M | 32 M | 33.4 M | 29.4 M | 29.3 M | 25.1 M | 27.5 M | 25 M | 28.3 M | 28.3 M | 26.4 M | 24.8 M | 25.5 M | 27.7 M | 27.4 M | 26.5 M | 27.2 M | 26.8 M | 23.1 M | 26.9 M | 26.8 M | 27.6 M | 26.6 M | 25.4 M | 23.4 M | 23.6 M | 25.4 M | 31.2 M | 22 M | 22 M | 23.1 M | 21.8 M | 25 M | 23 M | 21.8 M | 21.4 M | 22.1 M | 23.6 M | 19.9 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company CoreCivic (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.